Haleon commits Rs 2,000 cr for first India plant at Pithampur, online by 2029-30
The Sensodyne and Centrum maker will build its maiden Indian factory in Madhya Pradesh, anchored on oral-health output for domestic demand and Asian exports. The bet aligns with Haleon's global push to reach 1 billion consumers by 2030, up from 300 million today.
What happened
Haleon, maker of Sensodyne and Centrum, will invest Rs 2,000 crore in its first India manufacturing plant at Pithampur, Madhya Pradesh, primarily for
Key facts
- Rs 2,000 crore
- £175 million
- $14.55 billion
- 300 million consumers
- 1 billion consumers by 2030
- operational 2029-30
Why this matters
Haleon's first India plant reshapes the consumer health manufacturing map—watch for contract-manufacturing displacement, M&A in adjacent oral and VMS brands, and reactive capex from Hindustan Unilever, Colgate, and Procter & Gamble Health.